Jordan Rihani, MD
Otolaryngology · Southlake, TXNPI 1679703615
Payments from drug & device makers
What this record shows
This record is dominated by speaking fees: $208,540 of the $280,203 with a category attached, or 74.4%. Galderma Laboratories, L.p. accounts for 98.7% of it on its own, with 4 other manufacturers making up the rest. Reporting peaked in 2021 at $73,043 and has fallen 93.2% since, to $4,988 in 2025. Among otolaryngology clinicians in TX with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 268 payments — averaging $1045.53 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Galderma Laboratories, L.p.$277K
- Galderma Research & Development, LLC$3K
- AbbVie$449
- Integra Lifesciences Corporation$75
- Sientra, Inc.$54
What the payments were for
- Consulting fees$48,65017%
- Speaking & faculty fees$208,54074%
- Travel & lodging$16,6586%
- Food & beverage$6,3552%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Galderma Laboratories, L.p. | 257 | $276,650 |
| Galderma Research & Development, LLC | 1 | $2,975 |
| AbbVie | 6 | $449 |
| Integra Lifesciences Corporation | 3 | $75 |
| Sientra, Inc. | 1 | $54 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- BOTOX COSMETIC$119
- BOTOX$118
How this compares
$280,203 in reported general payments places this provider in the 95th percentile of 729 otolaryngology providers in Texas.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 34 | $309 |
| Cephalexin | 41 | $223 |
| Ondansetron Hcl | 23 | $48 |
Paid to pharmacies, not to this prescriber.
Other otolaryngology in Southlake
- Mary AshmeadSouthlake$141K
- Marc DeanFort Worth$486K
- Amber LuongHouston$426K
- Arjuna KuperanHouston$348K
- Ronald KuppersmithCollege Station$325K
- Ron KarniHouston$317K
- Philip ChenSan Antonio$305K
- Keith MathenyFrisco$269K
- Martin CitardiHouston$245K
- James AtkinsSan Antonio$205K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.